Colorectal Neoplasia and Screening
Colorectal neoplasia spans the growths that arise in the colon and rectum, from benign adenomatous polyps through invasive colorectal cancer, while screening refers to the organized detection of these lesions in people without symptoms. Because most colorectal cancers develop slowly from identifiable precursor lesions, the field is unusual in oncology for offering the opportunity both to detect cancer early and to prevent it by removing precursors.
Definition
Colorectal neoplasia is the development of neoplastic lesions in the colon and rectum, encompassing precancerous polyps and invasive carcinoma; screening is the application of tests to detect such lesions, or the cancers that follow from them, in asymptomatic individuals.
Scope
This area orients the reader to the biology of colorectal tumor development, the descriptive epidemiology and risk factors of colorectal cancer, the strategies used to screen average-risk and high-risk populations, and the principal hereditary syndromes that confer markedly elevated risk. It is a reference overview that frames its constituent topics rather than a source of clinical management instructions.
Sub-topics
Key concepts
- Adenomatous and serrated precursor lesions
- Adenoma-carcinoma sequence
- Average-risk versus high-risk screening
- Colonoscopy and polypectomy
- Stool-based and structural tests
- Hereditary colorectal cancer syndromes
Key theories
- Adenoma-carcinoma sequence
- Most colorectal cancers arise through a stepwise accumulation of genetic and epigenetic alterations that transform normal colonic epithelium into adenoma and then carcinoma, a multistep model that provides the rationale for detecting and removing precursor polyps.
Mechanisms
Colorectal cancers most often emerge from a precursor lesion through progressive molecular change, classically described as the adenoma-carcinoma sequence in which mutations and epigenetic events accumulate as epithelium progresses from normal mucosa to adenoma to carcinoma. Because this progression typically takes years, it creates a long pre-clinical window during which screening can detect early cancers and during which removal of adenomatous polyps can interrupt the pathway before cancer develops.
Clinical relevance
The area underlies a large part of preventive gastroenterology, because colorectal cancer is among the few common cancers for which removing a detectable precursor lesion can lower incidence. Reading these topics supports understanding of how detection and prevention strategies are conceived; the content describes the evidence base and is not a substitute for individualized clinical assessment.
Epidemiology
Colorectal cancer is one of the most commonly diagnosed cancers and a leading cause of cancer death worldwide, with substantial variation in incidence across regions and over time. Global cancer statistics rank it among the top cancers for both incidence and mortality, and trends including rising incidence in younger adults have drawn particular attention.
Evidence & guidelines
Randomized and long-term cohort evidence links polypectomy and screening to reductions in colorectal cancer incidence and mortality, and national bodies such as the US Preventive Services Task Force issue recommendation statements on whom and how to screen. These syntheses describe population-level evidence and recommendations rather than directing the care of any individual.
History
The modern framing of the field was shaped in the late twentieth century by the molecular description of colorectal tumorigenesis and by trials showing that colonoscopic polypectomy reduces subsequent cancer. These advances joined descriptive epidemiology and an expanding menu of screening tests to make colorectal cancer a model for cancer prevention.
Key figures
- Bert Vogelstein
- Eric Fearon
- Sidney Winawer
- Ann Zauber
Related topics
Seminal works
- fearon-vogelstein-1990
- winawer-1993
Frequently asked questions
- Why is colorectal cancer considered preventable through screening?
- Most colorectal cancers develop slowly from precursor polyps, so screening can both detect cancers early and remove precursor lesions before they become cancer, which can lower both incidence and mortality at the population level.
- What does this area cover?
- It orients readers to the biology of colorectal tumor development, the epidemiology and risk factors of colorectal cancer, screening strategies, and the major hereditary syndromes, linking to detailed topic entries for each.